TrialRheumatology (Oxford, England)2016

Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes.

Torbjörn Kullenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.